First Manhattan’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-40
| Closed | -$1K | – | 1565 |
|
|
2017
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 1416 |
|
|
2017
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 1375 |
|
|
2017
Q1 | $0 | Hold |
40
| – | – | ﹤0.01% | 1493 |
|
|
2016
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 1360 |
|
|
2016
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 1381 |
|
|
2016
Q2 | $0 | Hold |
40
| – | – | ﹤0.01% | 1561 |
|
|
2016
Q1 | $0 | Hold |
40
| – | – | ﹤0.01% | 1488 |
|
|
2015
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 1399 |
|
|
2015
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 1413 |
|
|
2015
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 1434 |
|
|
2015
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 1426 |
|
|
2014
Q4 | $0 | Hold |
40
| – | – | ﹤0.01% | 1569 |
|
|
2014
Q3 | $0 | Hold |
40
| – | – | ﹤0.01% | 1509 |
|
|
2014
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 1392 |
|
|
2014
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 1382 |
|
|
2013
Q4 | $0 | Hold |
40
| – | – | ﹤0.01% | 1442 |
|
|
2013
Q3 | $0 | Hold |
40
| – | – | ﹤0.01% | 1436 |
|
|
2013
Q2 | $0 | Buy |
+40
| New | +$567 | ﹤0.01% | 1403 |
|
First Manhattan's PMC Position: Q4 2017 in Review
First Manhattan sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 40 shares — an estimated $1K sold.
First Manhattan first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $1K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- First Manhattan reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- First Manhattan sold 40 PharMerica Corporation shares in Q4 2017, an estimated $1K.
- First Manhattan first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- First Manhattan's PharMerica Corporation position peaked at $1K in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on First Manhattan's 13F filing for Q4 2017, filed 22 Jan 2018.